PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-01-13

Date Title Company
13-Jan-2025 Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel Teva Pharmaceuticals
13-Jan-2025 GILEAD AND LEO PHARMA ENTER INTO STRATEGIC PARTNERSHIP TO ACCELERATE DEVELOPMENT OF ORAL STAT6 PROGRAM WITH POTENTIAL IN MULTIPLE INFLAMMATORY DISEASES Gilead Sciences, Inc.
13-Jan-2025 Rewards and financial incentives successfully help people to give up smoking University of East Anglia
13-Jan-2025 Frontage Announces Co-CEO Promotions Frontage Holdings Corporation
13-Jan-2025 Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technology Medtronic
13-Jan-2025 Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone Novavax
13-Jan-2025 Datopotamab deruxtecan granted Priority Review in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer AstraZeneca
13-Jan-2025 Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in Phase III studies Bayer
13-Jan-2025 Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries AccessWire
13-Jan-2025 Eckert & Ziegler and GlyTherix Extend Collaboration With Actinium-225 Supply Agreement Eckert & Ziegler SE
13-Jan-2025 IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets AccessWire
13-Jan-2025 Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma Heidelberg Pharma AG
13-Jan-2025 Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference AccessWire
13-Jan-2025 NanoViricides to Present at the Biotech Showcase in San Fransisco on Tuesday, January 14, 2025 AccessWire
13-Jan-2025 Frontage Announces Co-CEO Promotions AccessWire
13-Jan-2025 Teva becomes strategic commercialization partner for Formycon’s biosimilar candidate FYB203 (Eylea®/ aflibercept) in major parts of Europe and Israel Formycon AG
13-Jan-2025 Genflow Biosciences PLC Announces Holding(s) in Company - 2 AccessWire
13-Jan-2025 Genflow Biosciences PLC Announces Holding(s) in Company - 1 AccessWire